SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-057846
Filing Date
2021-09-27
Accepted
2021-09-27 19:56:19
Documents
2
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1546
2 EX-24 DOCUMENT attachment1.htm EX-24 2631
  Complete submission text file 0001209191-21-057846.txt   5658
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
GAROFALO ELIZABETH A. (Reporting) CIK: 0001826361 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38792 | Film No.: 211283215